Format

Send to

Choose Destination
Clin Microbiol Infect. 2014 Oct;20(10):973-80. doi: 10.1111/1469-0691.12798. Epub 2014 Nov 7.

Economic burden of antibiotic resistance: how much do we really know?

Author information

1
Center for Disease Dynamics, Economics & Policy, Washington, DC, USA.

Abstract

The declining effectiveness of antibiotics imposes potentially large health and economic burdens on societies. Quantifying the economic outcomes of antibiotic resistance effectively can help policy-makers and healthcare professionals to set priorities, but determining the actual effect of antibiotic resistance on clinical outcomes is a necessary first step. In this article, we review and discuss the contributions and limitations of studies that estimate the disease burden attributable to antibiotic resistance and studies that estimate the economic burden of resistance. We also consider other factors that are important in a comprehensive approach to evaluating the economic burden of antibiotic resistance.

KEYWORDS:

Antibiotic resistance; attributable morbidity and mortality; economics

PMID:
25273968
DOI:
10.1111/1469-0691.12798
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center